ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.

Emrah Gumusgoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.